ГОСТ ISO 10993-16-2016
Библиография
[1]AFZELIUS, L., et al., State-of-the-art tools for computational site of metabolism
predictions: Comparative analysis, mechanistic insights and future applications.
Drug. Metab. Revs.,39, pp. 61-86,2007
[2]BAILLIE, T.A., et al., Contemporary Issues in Toxicology: Drug Metabolites in
Safety Testing, Toxicol. Appl. Pharmacol., 182, pp. 188-196,2002
[3]WINTER, M.E. (ed), Basic clinical pharmacokinetics, 4th edition. Lippincott,
Williams & Wilkins, 2003
[4]BEATTY, DA and PIEGORSCH,W.W.,Optimal statistical design for toxicokinetic
studies, Statist. Meth. Med. Res.,6, pp. 359-376,1997
[5]BLAAUBOER, B.J., BARRATT, M.D. and HOUSTON,J.B., The Integrated Use of
Alternative Methods in Toxicological Risk Evaluation. ECVAM Integrated Testing
Strategies Task Force Report 1, ATLA.27, pp. 229-237,1999
[6]BOKKERS, B.G. and SLOB, W., Deriving a data-based interspecies assessment
factor using the NOAEL and the benchmark dose approach, Crit. Rev. Toxicol.,
37, pp. 355-373, 2007
[7]BOOBIS, A.R., et al., Interlaboratory comparison of the asessment of P450
activities in human hepatic microsomal samples, Xenobiotica, 28, pp. 493-506,
1998
[8]CLARK, D.E., (Theme ed), Computational methods for the prediction of ADME
andtoxicity, Adv. Drug. Deliv. Rev.,4, pp. 253-451,2002
[9]COSSON, V.F., FUSEAU, E., EFTHYMIOPOULOS, C. and BYE, A., Mixed Effect
Modeling of Sumatriptan Pharmacokinetics During Drug Development. I,
Interspecies Allometric Scaling, J. Pharmacokin. Pharmacod., 25, pp. 149-167,
1997
[10] CROSS, D.M. and BAYLISS, M.K., A commentary on the use of hepatocytes in
drug metabolism studies during drug discovery and drug development, Drug.
Metab. Revs., 32, pp. 219-240, 2000
[11] DIXIT, R., Toxicokinetics: Fundamentals and applications in drug development
and safety assessment, in Biological Concepts and Techniques in Toxicology,
Chapter8, pp. 117-160, Marcel Dekker2006
[12] DORNE, J.L., WALTON, К and RENWICK, A.G., Human variability in xenobiotic
metabolism and pathwayrelated uncertainty factors for chemical risk assessment:
15